The 68th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery

Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients with Prior Mechanical Valves

Ibrahim Marai 1 Gabby Elbaz-Greener 2 Nizar Andria 1 Ido Y Birrati 1 Ofer Amir 2 Guy Rozen 3
1Cardiovascular department, Poriya medical Center, Israel
2Cardiovascular Department, Hadassah Medical Center, Israel
3Cardiovascular Department, Hillel Yaffe Medical Center, Israel

Background. Background: Catheter ablation (CA) of atrial fibrillation (AF) is a well-established therapy for maintenance of sinus rhythm. Ablation of AF in patients with mechanical valves (MVs) is technically challenging.

Aim: To investigate the utilization and the real-world safety of CA for AF in patients with MVs.

Methods: Using data from the U.S. National Inpatient Sample (NIS), we identified patients with mitral/aortic MVs who required AF ablation in the indexed admission between 2003 and 2015. We compared the trajectory of AF ablation in patients with MVs over more than a decade as well as analyzed and compared the patient’s clinical characteristics, CA intra-operative complications, mortality and length of stay to matched patients without prior valve surgery who have undergone CA for the same indication.

Results: The study included a weighted total of 1898 CA for AF cases in patients with prior MVs patients. Mortality rate (0.2% vs. 0.2%, respectively, p=0.9) and complication rate (8.4% vs 10.4%, respectively, p=0.33) did not differ among patients with and without MVs. Length of stay was longer among patients with prior MVs compared to matched patients (4.0±0.2 vs. 3.3±0.2 days, respectively, p=0.011). Age group of 18-44 years was independently associated with lower rate of complications, while Deyo- Charlson Comorbidity Index 2 or higher, and Rural hospital status were associated with higher rate of complications.

Conclusion: Mortality and complication rates of AF ablation in patients with prior MVs were comparable to matched patients without MVs.









Powered by Eventact EMS